School of Nursing, Institute for Health and Aging, San Francisco, CA.
Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA.
Nicotine Tob Res. 2018 Sep 25;20(11):1359-1368. doi: 10.1093/ntr/ntx196.
This study estimated the health care utilization and expenditures attributable to the use of smokeless tobacco (ST) which includes chewing tobacco, snuff, dip, snus, and dissolvable tobacco among US adults aged 18 and older.
We used data from the 2012-2015 National Health Interview Surveys (n = 139451 adults) to estimate a zero-inflated Poisson (ZIP) regression model on four health care utilization measures among US adults (hospital nights, emergency room [ER] visits, doctor visits, and home care visits) specified as a function of tobacco use status, and other covariates. Tobacco use status was classified into four categories: current ST users, former ST users, non-ST tobacco users, and never tobacco users. ST-attributable utilization was calculated based on the estimated ZIP model using an "excess utilization" approach. It was then multiplied by the unit cost estimated from the 2014 Medical Expenditures Panel Survey data to derive ST-attributable health care expenditures.
During 2012-2015, 2.1% of adults were current ST users and 7.7% were former ST users. ST-attributable health care utilization amounted to 681000 hospital nights, 624000 ER visits, and 4.6 million doctor visits per year (home care visits results were not significant). This resulted in annual excess expenditures of $1.8 billion for hospitalizations, $0.7 billion for ER visits, and $0.9 billion for doctor visits, totaling over $3.4 billion (in 2014 dollars).
Comprehensive tobacco control policies and interventions are needed to reduce ST use and the associated health care burden.
This is the first study to assess the impact of ST use on health care burden in the United States. Findings indicate that excess annual health care expenditures attributable to ST use for US adults were $3.4 billion in 2014 dollars.
本研究估计了美国 18 岁及以上成年人使用无烟烟草(包括咀嚼烟草、鼻烟、口含烟、鼻烟和可溶解烟草)的卫生保健利用和支出。
我们使用 2012-2015 年全国健康访谈调查(n=139451 名成年人)的数据,根据烟草使用状况和其他协变量,对美国成年人四项卫生保健利用指标(住院夜数、急诊室就诊、医生就诊和家庭护理就诊)进行零膨胀泊松(ZIP)回归模型估计。烟草使用状况分为四类:当前无烟烟草使用者、曾经无烟烟草使用者、非无烟烟草使用者和从不吸烟使用者。基于估计的 ZIP 模型,使用“过度利用”方法计算无烟烟草相关的利用。然后,将其乘以 2014 年医疗支出面板调查数据估计的单位成本,得出无烟烟草相关的卫生保健支出。
2012-2015 年,2.1%的成年人是当前无烟烟草使用者,7.7%是曾经无烟烟草使用者。无烟烟草相关的卫生保健利用量为每年 681000 个住院夜数、624000 次急诊室就诊和 460 万次医生就诊(家庭护理就诊结果不显著)。这导致每年住院治疗的过度支出为 18 亿美元,急诊室就诊为 7 亿美元,医生就诊为 9 亿美元,总计超过 34 亿美元(按 2014 年美元计算)。
需要全面的烟草控制政策和干预措施来减少无烟烟草的使用和相关的卫生保健负担。
这是第一项评估美国无烟烟草使用对卫生保健负担影响的研究。研究结果表明,2014 年美国成年人因使用无烟烟草而导致的过度年度卫生保健支出为 34 亿美元。